IBDEI14Z ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41293,1,2,0)
 ;;=2^TCD Emboli Detect w/o Inj
 ;;^UTILITY(U,$J,358.3,41293,1,4,0)
 ;;=4^93892
 ;;^UTILITY(U,$J,358.3,41294,0)
 ;;=76881^^155^2020^31^^^^1
 ;;^UTILITY(U,$J,358.3,41294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41294,1,2,0)
 ;;=2^US Extrem Non Vasc,Complete
 ;;^UTILITY(U,$J,358.3,41294,1,4,0)
 ;;=4^76881
 ;;^UTILITY(U,$J,358.3,41295,0)
 ;;=76882^^155^2020^32^^^^1
 ;;^UTILITY(U,$J,358.3,41295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41295,1,2,0)
 ;;=2^US Extrem Non Vasc,Limited
 ;;^UTILITY(U,$J,358.3,41295,1,4,0)
 ;;=4^76882
 ;;^UTILITY(U,$J,358.3,41296,0)
 ;;=E10.40^^156^2021^82
 ;;^UTILITY(U,$J,358.3,41296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41296,1,3,0)
 ;;=3^DM Type 1 w/ DM Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,41296,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,41296,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,41297,0)
 ;;=E10.42^^156^2021^85
 ;;^UTILITY(U,$J,358.3,41297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41297,1,3,0)
 ;;=3^DM Type 1 w/ DM Polyneuropathy
 ;;^UTILITY(U,$J,358.3,41297,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,41297,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,41298,0)
 ;;=E10.43^^156^2021^79
 ;;^UTILITY(U,$J,358.3,41298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41298,1,3,0)
 ;;=3^DM Type 1 w/ DM Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,41298,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,41298,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,41299,0)
 ;;=E10.51^^156^2021^84
 ;;^UTILITY(U,$J,358.3,41299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41299,1,3,0)
 ;;=3^DM Type 1 w/ DM Periph Angiop w/o Gangrene
 ;;^UTILITY(U,$J,358.3,41299,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,41299,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,41300,0)
 ;;=E10.52^^156^2021^83
 ;;^UTILITY(U,$J,358.3,41300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41300,1,3,0)
 ;;=3^DM Type 1 w/ DM Periph Angiop w/ Gangrene
 ;;^UTILITY(U,$J,358.3,41300,1,4,0)
 ;;=4^E10.52
 ;;^UTILITY(U,$J,358.3,41300,2)
 ;;=^5002611
 ;;^UTILITY(U,$J,358.3,41301,0)
 ;;=E10.610^^156^2021^81
 ;;^UTILITY(U,$J,358.3,41301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41301,1,3,0)
 ;;=3^DM Type 1 w/ DM Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,41301,1,4,0)
 ;;=4^E10.610
 ;;^UTILITY(U,$J,358.3,41301,2)
 ;;=^5002613
 ;;^UTILITY(U,$J,358.3,41302,0)
 ;;=E10.620^^156^2021^80
 ;;^UTILITY(U,$J,358.3,41302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41302,1,3,0)
 ;;=3^DM Type 1 w/ DM Dermatitis
 ;;^UTILITY(U,$J,358.3,41302,1,4,0)
 ;;=4^E10.620
 ;;^UTILITY(U,$J,358.3,41302,2)
 ;;=^5002615
 ;;^UTILITY(U,$J,358.3,41303,0)
 ;;=E10.621^^156^2021^86
 ;;^UTILITY(U,$J,358.3,41303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41303,1,3,0)
 ;;=3^DM Type 1 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,41303,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,41303,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,41304,0)
 ;;=E10.622^^156^2021^91
 ;;^UTILITY(U,$J,358.3,41304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41304,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,41304,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,41304,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,41305,0)
 ;;=E10.630^^156^2021^90
 ;;^UTILITY(U,$J,358.3,41305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41305,1,3,0)
 ;;=3^DM Type 1 w/ Peridontal Disease
 ;;^UTILITY(U,$J,358.3,41305,1,4,0)
 ;;=4^E10.630
 ;;^UTILITY(U,$J,358.3,41305,2)
 ;;=^5002619
 ;;^UTILITY(U,$J,358.3,41306,0)
 ;;=E10.641^^156^2021^88
 ;;^UTILITY(U,$J,358.3,41306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41306,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,41306,1,4,0)
 ;;=4^E10.641
 ;;^UTILITY(U,$J,358.3,41306,2)
 ;;=^5002621
 ;;^UTILITY(U,$J,358.3,41307,0)
 ;;=E10.649^^156^2021^89
 ;;^UTILITY(U,$J,358.3,41307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41307,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,41307,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,41307,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,41308,0)
 ;;=E10.65^^156^2021^87
 ;;^UTILITY(U,$J,358.3,41308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41308,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,41308,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,41308,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,41309,0)
 ;;=E11.40^^156^2021^96
 ;;^UTILITY(U,$J,358.3,41309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41309,1,3,0)
 ;;=3^DM Type 2 w/ DM Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,41309,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,41309,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,41310,0)
 ;;=E11.42^^156^2021^99
 ;;^UTILITY(U,$J,358.3,41310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41310,1,3,0)
 ;;=3^DM Type 2 w/ DM Polyneuropathy
 ;;^UTILITY(U,$J,358.3,41310,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,41310,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,41311,0)
 ;;=E11.43^^156^2021^92
 ;;^UTILITY(U,$J,358.3,41311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41311,1,3,0)
 ;;=3^DM Type 2 w/ DM Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,41311,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,41311,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,41312,0)
 ;;=E11.49^^156^2021^94
 ;;^UTILITY(U,$J,358.3,41312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41312,1,3,0)
 ;;=3^DM Type 2 w/ DM Neurological Complications
 ;;^UTILITY(U,$J,358.3,41312,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,41312,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,41313,0)
 ;;=E11.51^^156^2021^98
 ;;^UTILITY(U,$J,358.3,41313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41313,1,3,0)
 ;;=3^DM Type 2 w/ DM Periph Angiop w/o Gangrene
 ;;^UTILITY(U,$J,358.3,41313,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,41313,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,41314,0)
 ;;=E11.52^^156^2021^97
 ;;^UTILITY(U,$J,358.3,41314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41314,1,3,0)
 ;;=3^DM Type 2 w/ DM Periph Angiop w/ Gangrene
 ;;^UTILITY(U,$J,358.3,41314,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,41314,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,41315,0)
 ;;=E11.610^^156^2021^95
 ;;^UTILITY(U,$J,358.3,41315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41315,1,3,0)
 ;;=3^DM Type 2 w/ DM Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,41315,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,41315,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,41316,0)
 ;;=E11.620^^156^2021^93
 ;;^UTILITY(U,$J,358.3,41316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41316,1,3,0)
 ;;=3^DM Type 2 w/ DM Dermatitis
 ;;^UTILITY(U,$J,358.3,41316,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,41316,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,41317,0)
 ;;=E11.621^^156^2021^100
 ;;^UTILITY(U,$J,358.3,41317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41317,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,41317,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,41317,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,41318,0)
 ;;=E11.622^^156^2021^105
 ;;^UTILITY(U,$J,358.3,41318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41318,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,41318,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,41318,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,41319,0)
 ;;=E11.630^^156^2021^104
 ;;^UTILITY(U,$J,358.3,41319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41319,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,41319,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,41319,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,41320,0)
 ;;=E11.641^^156^2021^102
 ;;^UTILITY(U,$J,358.3,41320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41320,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,41320,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,41320,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,41321,0)
 ;;=E11.649^^156^2021^103
 ;;^UTILITY(U,$J,358.3,41321,1,0)
 ;;=^358.31IA^4^2
